Second Generation Tiancimycin-Based Antibody–Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies
Alexander Kiefer(Scripps (United States)), Ben Shen(Scripps Research Institute), Pankajavalli Thirugnanasambantham(The Ohio State University), Christoph Rader(Scripps Research Institute), Dong Yang(Scripps Research Institute), Natarajan Muthusamy(The Ohio State University), Dobeen Hwang(Scripps (United States)), Rakeb Tafesse(The Ohio State University), Yuan Jin(Scripps (United States)), Jing Chang(Scripps (United States)), Yanlong Jiang(Peking University Shenzhen Hospital), Andrew D. Steele(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology), Ajeeth Adhikari(BD Biosciences (United States))
Cited by 2
Related Papers
Asymmetric Total Synthesis of Lancifodilactone G Acetate
|Journal of the American Chemical Society|2017|70
Biomimetically inspired asymmetric total synthesis of (+)-19-dehydroxyl arisandilactone A
|Nature Communications|2017|52
Asymmetric Total Synthesis of Pre-schisanartanin C
|Journal of the American Chemical Society|2019|49
Modular chemoenzymatic synthesis of ten fusicoccane diterpenoids
|Nature Chemistry|2024|30
The Natural Products Discovery Center: Release of the First 8490 Sequenced Strains for Exploring Actinobacteria Biosynthetic Diversity
|bioRxiv (Cold Spring Harbor Laboratory)|2023|16